Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

FLUNITRAZEPAM CRS - * PSY (100 MG)

FLUNITRAZEPAM CRS - * PSY (100 MG)

1622-62-4

DISCOVER
FLUOCINOLONE ACETONIDE CRS (110 MG)

FLUOCINOLONE ACETONIDE CRS (110 MG)

67-73-2

DISCOVER
Fluocortolone pivalate

Fluocortolone pivalate

29205-06-9

DISCOVER
FLUORESCEINE SODIUM - REFERENCE SPECTRUM (N/A)

FLUORESCEINE SODIUM - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
FLUOROURACIL CRS (35 MG)

FLUOROURACIL CRS (35 MG)

51-21-8

DISCOVER
Fluoxetine hydrochloride CRS,250mg

Fluoxetine hydrochloride CRS,250mg

56296-78-7

DISCOVER
FLUOXETINE IMPURITY B CRS (15MG)

FLUOXETINE IMPURITY B CRS (15MG)

23580-89-4

DISCOVER
FLUOXETINE IMPURITY C CRS (5 MG)

FLUOXETINE IMPURITY C CRS (5 MG)

79088-29-2

DISCOVER
FLUPHENAZINE DECANOATE CRS (50 MG)

FLUPHENAZINE DECANOATE CRS (50 MG)

5002-47-1

DISCOVER
FLUPHENAZINE DIHYDROCHLORIDE CRS (50 MG)

FLUPHENAZINE DIHYDROCHLORIDE CRS (50 MG)

146-56-5

DISCOVER
FLURBIPROFEN CRS (50 MG)

FLURBIPROFEN CRS (50 MG)

5104-49-4

DISCOVER
FLURBIPROFEN IMPURITY A CRS (25 MG)

FLURBIPROFEN IMPURITY A CRS (25 MG)

NA

DISCOVER